1. Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review;Schoffski;Annals of Oncology,2006
2. Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors;Desai;Annals of Internal Medicine,2006
3. 3 Martorella, A.J. , Omry, G. , Hann, L.E. , Motzer, R.J. & Robbins, R.J. (2006) Receptor tyrosine kinase (RTK) inhibitor SU11248 may cause primary hypothyroidism in a select group of patients with metastatic renal cell carcinoma (RCC). US Endocrine Society Meeting, Boston MA P3-593.
4. Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib;Rini;Journal of the National Cancer Institute,2007
5. Sunitinib and hypothyroidism;Wolter;New England Journal of Medicine,2007